CoChat

Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas

Open access
Forlenza, Gregory P., Buckingham, Bruce, Maahs, David M. · 2016 · The Journal of Pediatrics
Cited by 58

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

T ype 1 diabetes (T1D) is one of the most common chronic diseases of childhood with an estimated prevalence of more than 166 000 cases in children younger than 20 years of age in the US in 2010. The rate of new-onset diabetes also is increasing worldwide, with an increased incidence of 3%-5% per year. In 1993 the Diabetes Control and Complications Trial established the benefit of intensive insulin therapy in reducing long-term complications, including retinopathy, nephropathy, and neuropathy. Despite this now longstanding knowledge, vascular complications attributable to hyperglycemia remain a significant issue in the T1D population, even in the young-adult population. Recent evidence from the T1D Exchange clinic registry shows that during childhood mean hemoglobin A1c (HbA1c) remains above the target of 7.5% for all age groups, with a peak of 9.2% in the late teenage years. This evidence points toward the urgent need for better therapeutic interventions to improve glycemic control across the pediatric population. Innovations in diabetes care are being pursued on many fronts, including education, behavioral interventions, pharmaceutical development, beta-cell transplantation, and immunomodulation to prevent autoimmune beta-cell destruction. Although these therapies aim to provide benefit now andmore so in the future, many in the diabetes community believe that the most impactful near-term benefit will be achieved by innovation in the technologies used to manage diabetes. Portable subcutaneous continuous insulin infusion (CSII) pumps first became possible in the early 1970s and achieved improved glycemic control in early studies. Publication of the Diabetes Control and Complications Trial in 1993 demonstrated the importance of strict glycemic control and with it increased interest in the use of technology tominimize hyperglycemia without increasing hypoglycemia, still considered the greatest barrier to tight glucose control. The late 1990s and early 2000s saw rapid expansion in design and availability of CSII systems as research showed improved outcomes with use of this technology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpeds.2015.10.015

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 58

Metadata

Authors
Forlenza, G. P., Buckingham, B., & Maahs, D. M.
Venue
The Journal of Pediatrics
Publisher
Elsevier BV
Published
2016-02
Volume
169
Pages
13-20
ISSN
0022-3476 (ISSN-L)
OpenAlex
W2212493618
Cited by
58
References
13
FWCI
7.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. https://app.cochat.ai/papers/10.1016/j.jpeds.2015.10.015
The paper
Forlenza, G. P., Buckingham, B., & Maahs, D. M. (2016). Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2015.10.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.